Vanguard Group
ZSAN

Vanguard Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Vanguard Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-147,112
Closed -$1.16M – 4685
2022
Q1 		$1.16M Buy
147,112
+23,380
+19% +$257K ﹤0.01% 4162
2021
Q4 		$2.04M Buy
123,732
+242
+0.2% +$5.11K ﹤0.01% 4030
2021
Q3 		$3.11M Buy
123,490
+2,692
+2% +$69.8K ﹤0.01% 3902
2021
Q2 		$4.02M Buy
120,798
+11,310
+10% +$365K ﹤0.01% 3700
2021
Q1 		$4.75M Buy
109,488
+8,264
+8% +$346K ﹤0.01% 3558
2020
Q4 		$1.87M Buy
101,224
+10,231
+11% +$200K ﹤0.01% 3682
2020
Q3 		$5.16M Buy
90,993
+51,086
+128% +$2.38M ﹤0.01% 3129
2020
Q2 		$1.2M Buy
39,907
+1,050
+3% +$29.6K ﹤0.01% 3567
2020
Q1 		$765K Buy
38,857
+11,684
+43% +$392K ﹤0.01% 3565
2019
Q4 		$1.45M Hold
27,173
– – ﹤0.01% 3538
2019
Q3 		$1.48M Sell
27,173
-171
-0.6% -$15.3K ﹤0.01% 3542
2019
Q2 		$3.13M Buy
27,344
+14,838
+119% +$1.76M ﹤0.01% 3330
2019
Q1 		$2.09M Buy
12,506
+7,375
+144% +$904K ﹤0.01% 3434
2018
Q4 		$381K Sell
5,131
-10,245
-67% -$1.3M ﹤0.01% 3787
2018
Q3 		$2.2M Sell
15,376
-505
-3% -$74K ﹤0.01% 3496
2018
Q2 		$2.27M Buy
15,881
+5,255
+49% +$791K ﹤0.01% 3462
2018
Q1 		$1.87M Buy
10,626
+9,211
+651% +$3.08M ﹤0.01% 3479
2017
Q4 		$515K Sell
1,415
-393
-22% -$197K ﹤0.01% 3742
2017
Q3 		$1.04M Buy
1,808
+69
+4% +$50.6K ﹤0.01% 3579
2017
Q2 		$1.72M Buy
1,739
+299
+21% +$309K ﹤0.01% 3425
2017
Q1 		$1.92M Buy
1,440
+1,345
+1,416% +$1.62M ﹤0.01% 3393
2016
Q4 		$52K Hold
95
– – ﹤0.01% 4029
2016
Q3 		$50K Sell
95
-35
-27% -$27.9K ﹤0.01% 4034
2016
Q2 		$120K Hold
130
– – ﹤0.01% 4008
2016
Q1 		$208K Hold
130
– – ﹤0.01% 3955
2015
Q4 		$202K Buy
130
+1
+0.8% +$1.95K ﹤0.01% 4015
2015
Q3 		$359K Buy
+129
New +$724K ﹤0.01% 3933

Other funds holding ZSAN

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group's ZSAN Position: Q2 2022 in Review

Vanguard Group sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 147,112 shares — an estimated $1.16M sold.

Vanguard Group first reported a position in ZSAN in Q3 2015 and held it in 27 quarters. The position peaked at $5.16M in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

  • Vanguard Group reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
  • Vanguard Group sold 147,112 Zosano Pharma Corporation shares in Q2 2022, an estimated $1.16M.
  • Vanguard Group first reported a position in Zosano Pharma Corporation in Q3 2015 and held it in 27 quarters.
  • Vanguard Group's Zosano Pharma Corporation position peaked at $5.16M in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.